GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Operating Cash Flow | -117.75M | -200.62M | |
| Depreciation & Amort | 15.35M | 13.18M | |
| Capital Expenditure | -3.45M | -3.51M | |
| Free Cash Flow | -121.20M | -204.13M | |
| Investing Cash Flow | -57.73M | 116.77M | |
| Financing Cash Flow | 91.33M | 28.06M |
Revenue CAGR
+55.9%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+55.9%